Related Experiment Video
Updated: Oct 12, 2025

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
Reversal of Opioid Intoxication in an Infant With Intrauterine Growth Restriction With a Single Dose of Naloxone
Utsav Timalsina1, Ann Andrasovich1, Fernanda E Kupferman1
1Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, USA.
Insights
Naloxone may be cautiously used in newborns with opioid exposure and respiratory distress, especially those with intrauterine growth restriction (IUGR). This case highlights its potential benefit when administered carefully to opioid-intoxicated infants.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Developmental Pediatrics
Background:
- Perinatal opioid exposure can lead to neonatal opioid intoxication.
- Routine naloxone use in newborns is generally discouraged due to risks of withdrawal and developmental issues.
- Intrauterine growth restriction (IUGR) presents unique challenges in neonatal care.
Observation:
- A neonate with IUGR exposed to opioids in utero presented with respiratory and neurological depression at birth.
- Initial positive pressure ventilation improved the infant's tone and respiratory effort.
- Delayed bradypnea, shallow breathing, and oxygen desaturation occurred eight hours after birth.
Findings:
- A single dose of intravenous naloxone successfully reversed the respiratory and neurological depression.
- The infant, exposed to hydromorphone, showed significant improvement post-naloxone administration.
- The infant was discharged on day seven with no residual symptoms.
Implications:
- Naloxone administration may be considered for IUGR infants with persistent cardiorespiratory and neurological depression following recent intrauterine opioid exposure.
- Careful consideration is needed, particularly if the mother is not narcotic dependent.
- This case suggests a potential role for naloxone in specific neonatal opioid intoxication scenarios.
Abstract:
Perinatal exposure to opioids might result in opioid intoxication in a newborn infant. The routine use of naloxone in an opioid-exposed newborn infant is discouraged due to the risks of precipitating withdrawal and long-term developmental problems associated with naloxone. We describe a case of respiratory and neurological depression in an infant with intrauterine growth restriction (IUGR) following in utero exposure to an opioid two hours before delivery. The infant was apneic with a poor tone immediately after birth. With positive pressure ventilation, the tone and respiratory effort improved, and the baby was admitted to the neonatal intensive care unit (NICU) on oxygen support via nasal cannula. The baby started having bradypnea with shallow breathing and oxygen desaturation at eight hours of life, most likely secondary to intrauterine exposure to hydromorphone which was successfully reversed with a single dose of intravenous naloxone. The infant was discharged on day of life seven with no further symptoms. Naloxone administration might be considered in an IUGR infant with persistent cardiorespiratory and neurological depression who has a history of intrauterine opioid exposure within four hours before delivery provided the mother is not narcotic dependent.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Dosing: Infants and Children
Parenteral Anesthetics: Overview
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Factors Affecting Drug Response: Overview

